These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
96 related items for PubMed ID: 9829757
1. Pharmacokinetics of O6-benzylguanine and its active metabolite 8-oxo-O6-benzylguanine in plasma and cerebrospinal fluid after intrathecal administration of O6-benzylguanine in the nonhuman primate. Berg SL, Murry DJ, McCully CL, Godwin K, Balis FM. Clin Cancer Res; 1998 Nov; 4(11):2891-4. PubMed ID: 9829757 [Abstract] [Full Text] [Related]
2. Plasma and cerebrospinal fluid pharmacokinetics of O6-benzylguanine and time course of peripheral blood mononuclear cell O6-methylguanine-DNA methyltransferase inhibition in the nonhuman primate. Berg SL, Gerson SL, Godwin K, Cole DE, Liu L, Balis FM. Cancer Res; 1995 Oct 15; 55(20):4606-10. PubMed ID: 7553637 [Abstract] [Full Text] [Related]
3. Plasma and cerebrospinal fluid pharmacokinetics of O6-benzylguanine and analogues in nonhuman primates. Long L, Berg SL, Roy SK, McCully CL, Song-Yoo HW, Moschel RC, Balis FM, Dolan ME. Clin Cancer Res; 2000 Sep 15; 6(9):3662-9. PubMed ID: 10999759 [Abstract] [Full Text] [Related]
4. Simultaneous determination of O6-benzylguanine and 8-oxo-O6-benzylguanine in human plasma by reversed-phase high-performance liquid chromatography. Stefan TL, Ingalls ST, Minkler PE, Willson JK, Gerson SL, Spiro TP, Hoppel CL. J Chromatogr B Biomed Sci Appl; 1997 Dec 19; 704(1-2):289-98. PubMed ID: 9518162 [Abstract] [Full Text] [Related]
5. Pharmacokinetics of O6-benzylguanine in rats and its metabolism by rat liver microsomes. Roy SK, Gupta E, Dolan ME. Drug Metab Dispos; 1995 Dec 19; 23(12):1394-9. PubMed ID: 8689950 [Abstract] [Full Text] [Related]
6. Pharmacokinetics of O6-benzylguanine (NSC637037) and its metabolite, 8-oxo-O6-benzylguanine. Tserng KY, Ingalls ST, Boczko EM, Spiro TP, Li X, Majka S, Gerson SL, Willson JK, Hoppel CL. J Clin Pharmacol; 2003 Aug 19; 43(8):881-93. PubMed ID: 12953345 [Abstract] [Full Text] [Related]
7. Pharmacokinetics of O(6)-benzylguanine in pediatric patients with central nervous system tumors: a pediatric oncology group study. Neville K, Blaney S, Bernstein M, Thompson P, Adams D, Aleksic A, Berg S. Clin Cancer Res; 2004 Aug 01; 10(15):5072-5. PubMed ID: 15297409 [Abstract] [Full Text] [Related]
9. O6-benzylguanine in humans: metabolic, pharmacokinetic, and pharmacodynamic findings. Dolan ME, Roy SK, Fasanmade AA, Paras PR, Schilsky RL, Ratain MJ. J Clin Oncol; 1998 May 01; 16(5):1803-10. PubMed ID: 9586894 [Abstract] [Full Text] [Related]
15. Cerebrospinal fluid pharmacokinetics and toxicology of intraventricular and intrathecal arabinosyl-5-azacytosine (fazarabine, NSC 281272) in the nonhuman primate. Heideman RL, McCully C, Balis FM, Poplack DG. Invest New Drugs; 1993 May 01; 11(2-3):135-40. PubMed ID: 7505267 [Abstract] [Full Text] [Related]
16. O6-benzylguanine: a clinical trial establishing the biochemical modulatory dose in tumor tissue for alkyltransferase-directed DNA repair. Spiro TP, Gerson SL, Liu L, Majka S, Haaga J, Hoppel CL, Ingalls ST, Pluda JM, Willson JK. Cancer Res; 1999 May 15; 59(10):2402-10. PubMed ID: 10344750 [Abstract] [Full Text] [Related]
17. Effect of O6-benzylguanine on the sensitivity of human tumor xenografts to 1,3-bis(2-chloroethyl)-1-nitrosourea and on DNA interstrand cross-link formation. Mitchell RB, Moschel RC, Dolan ME. Cancer Res; 1992 Mar 01; 52(5):1171-5. PubMed ID: 1737376 [Abstract] [Full Text] [Related]